Sandra Maddock, CEO and President of IMARC Research, was featured in the March 24th edition of MedCity News.  Click here to review the entire article.

IMARC assists the clinical research community in the pursuit of FDA and worldwide approvals. Our effectiveness is built on preparing, educating, complementing and guiding site teams from Day 1 — to control the complex management of trials via cost-effective monitoring, auditing and training services — which results in the support, proof and assurance they seek to overcome chaos caused by complexity while achieving compliance through consistency. Providing committed, competent and confident consultation is how IMARC sets the highest standards for site outcomes and study partnerships.

MedCity News -- (LinkedIn company profile) -- is a content provider. It delivers original reporting and custom-content for organizations and individuals with a vested interest in health care. It is a solution for media companies and organizations that need content, stakeholders who need actionable information about the medical industry, and advertisers who want to speak to this valuable niche audience.

Founded by veteran journalists with both health care reporting and online editorial experience, MedCity News is poised to build an innovative new-media enterprise capable of taking advantage of the converging forces of media change and the emerging power of health care while building a profitable national business and brand.

IMARC has recently moved into a new headquarters in Fairview Park, Ohio and has been in business since 1999.